Biblio Discovery — Demo Discovery Service

817 hasil

Menampilkan 1–20 · 0,72 detik · RSS

Jurnal

Journal of Alzheimer's Disease Reports

Scopus

ISSN 2542-4823 · SAGE Publishing · 817 artikel di indeks

  1. Artikel Jurnal

    For patients living in the “Dementia Gap”, a newly defined substage of late-stage Alzheimer's disease, with intolerable suffering: Can sedation to unconsciousness be moral?

    Stanley A. Terman

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Advanced Alzheimer's disease is a terminal illness causing more intense, prolonged suffering than clinicians generally recognize. At least 500,000 Americans are trapped in the “Dementia Gap”, a previously unidentified substage of advanced dementia. Patients lack capacity to voluntarily stop eating…

  2. Artikel Jurnal

    Perspectives on plasma biomarkers for point-of-care diagnostics in Alzheimer's disease: Insights into 2D-BioPAD

    Angeliki Koukoura; Kyriaki Antonopoulou; Apostolos C Tsolakis dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    We investigated the potential of plasma biomarkers for point-of-care in vitro diagnostics in Alzheimer's disease by collecting insights from 99 stakeholders primarily from Greece, including patients, caregivers, healthcare professionals, and researchers. Data from an online survey was analyzed…

  3. Artikel Jurnal

    Deep brain stimulation in Alzheimer's disease

    Zain Majeed; Jad Majeed; Francisco A Ponce dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Deep brain stimulation (DBS) is a well-established treatment for neurological disorders, but its efficacy and safety in Alzheimer's disease (AD) remain uncertain. This narrative review synthesizes nine clinical trials in patients with mild to severe AD, focusing on stimulation of the fornix…

  4. Artikel Jurnal

    Uptake and safety profile of anti-amyloid immunotherapies in routine clinical practice

    Jay B. Lusk; Kate Vinita Fitch; Kim G. Johnson dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Background Anti-amyloid immunotherapies are approved by the United States Food and Drug Administration for the treatment of Alzheimer's disease; however, the adoption and safety profile of these medications in routine clinical practice have not been described. Objective To describe the adoption and…

  5. Artikel Jurnal

    The trajectory of delusions in patients with Alzheimer's disease receiving pharmacological treatment: A re-analysis of data from the CATIE-AD trial

    Katsuharu Yano; Tomoyuki Nagata; Shinichiro Nakajima dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Background Previous studies have reported decreases in the proportion of patients with delusions and severity of delusions during long-term follow-up in Alzheimer's disease (AD). Objective The aim of the present study was to explore clinical predictors of the disappearance of delusions in AD…

  6. Artikel Jurnal

    Brain health in older adults: At the crossroads of frailty and resilience

    Mohammad Shahadat Hossain; Domenico Praticò

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Brain health is a state of physiological functioning of the organ that allows individuals to fully achieve their age-related potential. Throughout life, a wide range of endogenous and exogenous factors can influence positively and negatively brain health. Among them, age is undoubtedly one of the…

  7. Artikel Jurnal

    Dissecting the sex-dependent muscle–brain axis: Hippocampal subfields mediate the association between grip strength and cognition in amnestic mild cognitive impairment

    Wen-Juan Song; Guo-Hui Zhang; Pu Zhao dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Background Grip strength has been increasingly recognized as a potential indicator of cognitive decline and is closely associated with hippocampal structure. However, whether this muscle–brain relationship differs by sex among individuals with amnestic mild cognitive impairment (aMCI) remains…

  8. Artikel Jurnal

    Antioxidant intake relative to established dietary recommendations and cognitive status in older adults

    Kelly Knoll; Halli Heimbuch; Ryan McGrath dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Background Oxidative stress, the imbalance of prooxidants and antioxidants, has been recognized as a contributor in the development of age-related cognitive decline and Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). Exogenous antioxidant intake may play a role in…

  9. Artikel Jurnal

    Critical review of the foundational studies on chronic traumatic encephalopathy in American football players

    Ira R. Casson; David C. Viano

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Background Chronic traumatic encephalopathy (CTE) was first reported in American football players twenty years ago and has generated ongoing discussion in the medical/scientific community. Objective The purposes of this paper are twofold: (1) to critically analyze the methodology and evidence…

  10. Artikel Jurnal

    Artificial intelligence algorithms for the prediction of cognitive decline and dementia: A theoretical–historical narrative review

    Rubén Sanz-Blasco; Miguel Ángel Fernández-Blázquez; Emilio Verche dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Population aging has increased the prevalence of neurodegenerative disorders associated with dementia, with Alzheimer's disease remaining the leading cause worldwide. Early identification of individuals at risk of cognitive decline, particularly those with mild cognitive impairment, remains a major…

  11. Artikel Jurnal

    Safety, acceptability, and usability of an immersive gamification technology system for use in patients with behavioral and psychological symptoms of dementia (phase 1 trial)

    Veeda Michelle M. Anlacan; Roland Dominic G. Jamora; Angelo Cedric F. Panganiban dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Background Virtual reality (VR) is increasingly explored as a novel non-pharmacologic approach to manage Alzheimer's disease, particularly the behavioral and psychological symptoms of dementia. Objective This phase 1 study aimed to develop an immersive gamification technology system (ImGTS) for the…

  12. Artikel Jurnal

    Assessment of an automated telesurveillance system on serious falls prevention in an elderly suffering from dementia specialized care unit: The URCC GET-BETTER study (geriatric environmental telecare – behavioral engineering technology to enhance rehabilitation)

    Abdoul Razak Sawadogo; Caroline Gayot; Amadou Maguette Djiogomaye Ndiaye dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Background “ Unités de réadaptation cognitivo-comportementale (URCC)” are specialized units for patients with Alzheimer's disease or related dementias presenting behavioral disorders. Falls are frequent in these settings, with dementia increasing fall risk six-fold. Detection remains difficult…

  13. Artikel Jurnal

    Studies on the effect of curcumin and its glucoside derivatives on IMR-32 neuroblastoma cell lines

    Lakshmi Sowmya Emani; Harshitha Mahesha; Soumyadip Mullick dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Background The hallmark pathologies of neurodegenerative diseases include neuroinflammation, oxidative stress, mitochondrial dysfunction, protein misfolding, and dysregulated cell-survival signaling. These biochemical processes lead to neuronal death in disorders such as Alzheimer's disease…

  14. Artikel Jurnal

    Peptide vaccination for Alzheimer's disease: Immunological foundations, therapeutic potential, and translational barriers

    Haoteng Chen; Yuanxiang Lin; DeZhi Kang dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    In recent years, increasing attention has been directed toward the role of immune responses in the pathogenesis of Alzheimer's disease (AD). The pathological proteins amyloid-β (Aβ) and tau protein are closely associated with immune dysregulation and neuroinflammatory processes during AD…

  15. Artikel Jurnal

    Impact of aging and body mass index on self-reported cognitive impairment among West Texas adults: Implications for better lifestyle

    Hafiz Khan; Lamourdia Dayamba; Aamrin Rafiq dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Background Alzheimer's disease (AD) is an increasing public health concern, especially among adults over age 40 in rural regions, where chronic conditions are prevalent and healthcare resources are limited. Objective This study aimed to determine the impact of aging and body mass index (BMI) on…

  16. Artikel Jurnal

    Neurons on the rocks: A case of alcohol use and early onset Alzheimer's disease

    Evan G. Starr; Jasleen Dhaliwal; Michael G. McLatchey dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    A 46-year-old female was admitted to the hospital for confusion, cognitive decline, and hallucinations with alcohol withdrawal. Her history was notable for Alcohol use disorder (AUD) and family history of Alzheimer's disease (AD). Comprehensive workup was unrevealing for metabolic encephalopathy…

  17. Artikel Jurnal

    Nipah virus infection as a putative risk factor for Alzheimer's disease: A testable hypothesis

    Navakanth Raju Ramayanam; Sarad Pawar Naik Bukke; Badvel Jeevan Kumar dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Nipah virus is a neurotropic paramyxovirus known to cause severe acute encephalitis and delayed or relapsing neurological syndromes. Increasing evidence suggests that both systemic infections and central nervous system inflammation may act as contributors to, or accelerators of, Alzheimer's disease…

  18. Artikel Jurnal

    Steroid-responsive inflammatory leptomeningeal encephalitis temporally associated with lecanemab therapy: A case report

    Yuichiro Tagane; Masahiro Nakamori; Marina Ishida dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Lecanemab is an anti–amyloid-β monoclonal antibody used for the treatment of early Alzheimer's disease. Herein, we report a 46-year-old woman who developed headache, fever, disorientation, and impaired consciousness 10 months after starting lecanemab. Magnetic resonance imaging revealed a small…

  19. Artikel Jurnal

    Symptomatic lobar intracerebral hemorrhage during extended lecanemab treatment: A case report

    Yugo Takahashi; Naoyuki Shiraishi; Akihiro Tsukahara dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Lecanemab is an anti-amyloid-β protofibril antibody that slows cognitive decline in early Alzheimer's disease. Although amyloid-related imaging abnormalities (ARIA) occur predominantly early in treatment, reports of hemorrhagic events during extended treatment beyond 18 months remain limited. A…

  20. Artikel Jurnal

    Donanemab-associated clinical improvement in Alzheimer's disease presenting predominantly with neuropsychiatric symptoms: A case report

    Yehao Jiang; Huamei Lin; Bo Hong dkk.

    Journal of Alzheimer's Disease Reports, Vol. 10 · 2026 · Inggris · DOAJ Scopus

    Late-life depression may mask Alzheimer's disease (AD). We report a 78-year-old man with treatment-refractory depressive and anxiety symptoms accompanied by paroxysmal somatic attacks, unresponsive to psychotropic treatment and modified electroconvulsive therapy. Ultimately, biomarker evaluation…